| |
| |
|
| Insider
Information: |
Pace Gary W |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
863,822 |
|
|
Indirect Shares
|
540,919 |
|
|
| Direct
Value |
$22,979,924 |
|
|
|
Indirect Value
|
$20,375,505 |
|
|
| Total
Shares |
1,404,741 |
|
|
| Total
Value |
$43,355,428 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
6
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
6
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-6.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -112.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
ResMed Inc |
RMD |
Director |
2018-05-08 |
100,578 |
2015-01-26 |
93,158 |
Premium* |
|
|
Celsion Corp |
CLSN |
Director |
2008-12-04 |
43,356 |
2003-12-22 |
0 |
Premium* |
|
|
Pacira Pharmaceuticals, Inc. |
PCRX |
Director |
2024-03-08 |
22,127 |
2011-11-21 |
0 |
Premium* |
|
|
Cardiff Oncology Inc |
CRDF |
Director |
2023-12-19 |
697,761 |
2020-05-11 |
447,761 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
81 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RMD |
ResMed Inc |
Director |
– • – |
2018-05-08 |
4 |
S |
$97.37 |
$2,765,600 |
D/D |
(28,403) |
100,578 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2018-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
782 |
24,319 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2018-11-07 |
4 |
B |
$51.29 |
$205,160 |
D/D |
4,000 |
28,319 |
2.39 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2018-11-19 |
4 |
B |
$46.18 |
$207,810 |
D/D |
4,500 |
32,819 |
2.39 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2019-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
4,134 |
36,953 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2020-03-12 |
4 |
OE |
$1.61 |
$96,845 |
D/D |
21,736 |
58,689 |
0 |
- |
|
| CRDF |
Cardiff Oncology Inc |
Director |
– • – |
2020-05-11 |
4 |
B |
$1.34 |
$600,000 |
I/I |
447,761 |
447,761 |
2.1 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2020-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,260 |
59,949 |
0 |
- |
|
| CRDF |
Cardiff Oncology Inc |
Director |
– • – |
2020-09-16 |
4 |
B |
$5.69 |
$14,527 |
D/D |
2,550 |
450,311 |
2.39 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2020-09-25 |
4 |
OE |
$16.67 |
$1,166,900 |
D/D |
70,000 |
129,949 |
0 |
- |
|
| CRDF |
Cardiff Oncology Inc |
Director |
– • – |
2021-03-04 |
4 |
B |
$9.27 |
$13,898 |
D/D |
1,500 |
451,811 |
2.39 |
- |
|
| CRDF |
Cardiff Oncology Inc |
Director |
– • – |
2021-03-18 |
4 |
B |
$10.54 |
$31,660 |
D/D |
3,000 |
454,811 |
2.39 |
- |
|
| CRDF |
Cardiff Oncology Inc |
Director |
– • – |
2021-03-23 |
4 |
B |
$10.20 |
$102,300 |
D/D |
10,000 |
464,811 |
2.39 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2021-05-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,485 |
128,464 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2021-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,066 |
129,530 |
0 |
- |
|
| CRDF |
Cardiff Oncology Inc |
Director |
– • – |
2021-09-21 |
4 |
B |
$6.75 |
$202,500 |
D/D |
30,000 |
494,811 |
2.39 |
% |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2022-02-28 |
4 |
OE |
$11.02 |
$315,624 |
D/D |
28,641 |
158,171 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2022-02-28 |
4 |
S |
$66.83 |
$1,914,078 |
D/D |
(28,641) |
129,530 |
0 |
% |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2022-03-01 |
4 |
OE |
$11.02 |
$14,976 |
D/D |
1,359 |
130,889 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2022-03-01 |
4 |
S |
$67.75 |
$92,072 |
D/D |
(1,359) |
129,530 |
0 |
% |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2022-03-03 |
4 |
OE |
$10.81 |
$75,670 |
D/D |
7,000 |
136,530 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2022-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
1,160 |
137,690 |
0 |
- |
|
| CRDF |
Cardiff Oncology Inc |
Director |
– • – |
2022-09-15 |
4 |
B |
$1.71 |
$256,500 |
D/D |
150,000 |
644,811 |
2.39 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2023-05-11 |
4 |
OE |
$29.90 |
$209,300 |
D/D |
7,000 |
144,690 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2023-05-11 |
4 |
S |
$41.78 |
$209,527 |
D/D |
(5,015) |
139,675 |
0 |
% |
|
81 Records found
|
|
Page 3 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
